Vaccination News Home Page

http://www.medscape.com/viewarticle/437495?srcmp=ped-070502&WebLogicSession=PTMDXy9S8jN2cXRVx4EpuG6qKOH96YJg3fW21vwYaI1V8n2nwJcl|6442268040773019234/-1408233355/6/7001/7001/7002/7002/7001/-1

Medscape

 
My Home Page Shortcuts Check Mail Account Settings Log Out REGISTRATION SignIn
MEDLINE Drug Info More...
BROWSE
SEARCH



 

Welcome, S M



HomeCME CenterConference CenterLibraryDiscussionsMarketplaceHelp July 15, 2002  
Email to a Colleague Printable Version Add to My Shortcuts
Publication Logo
PUFA-Enriched Formula Does Not Improve Neurodevelopment of Preterm Infants


 

 


 

NEW YORK (Reuters Health) Jul 01 - Infant formula supplemented with long-chain polyunsaturated fatty acid (PUFA) does not improve the neurodevelopmental outcomes of preterm infants, according to a report in the July issue of Pediatrics.

Breast milk contains long-chain PUFA, which is found in high concentrations in cell membranes, particularly those of the central nervous system, and is thought to play an important role in brain development.

Because standard infant formula does not contain long-chain PUFA, researchers have reasoned that formula supplemented with this fatty acid would benefit preterm infants whose brains have not fully matured. But studies to date have yielded conflicting results.

In the current study, neurodevelopmental test results at 9 and 18 months did not differ significantly among 195 preterm infants, regardless of whether they were fed long-chain PUFA-supplemented formula or standard formula while in the hospital.

However, at 18 months, the children who had been fed the supplemented formula showed a slight trend toward better developmental scores, especially among those born before 30 weeks of pregnancy, study author Dr. Mary S. Fewtrell, from the Institute of Child Health in London, and colleagues note.

While this finding could have been due to chance, the researchers believe it warrants further study because it is possible that children given long-chain PUFA-supplemented formula will show measurable gains later in life.

"Failure to demonstrate a significant effect of long-chain PUFA supplementation on global tests of development during infancy does not exclude the possibility of more subtle effects, which might become apparent at a later age, when more detailed neurocognitive testing is possible," they write. "This emphasizes the need for long-term follow-up of infants enrolled in supplementation studies, currently being planned for our cohort."

But the researchers also note that there are concerns with the supplemented formula. At 18 months, children in this group were shorter and lighter than those given standard formula.

Furthermore, a group of 88 control infants who were breastfed scored higher on developmental tests than either group of formula-fed infants.

Pediatrics 2002;110:73-82.

 

 

Related Links

Related Resource Centers

Nutrition

 




Return to article


 

   

Reuters Health Information 2002. © 2002 Reuters Ltd.
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.



 

 


 


 

 


 


Related Resources
 
Clinical articles on this topic

Consumer health articles on this topic

 

Keyword Search   Advanced Search
 
Medscape  DrugInfo 
Patient Info    MEDLINE 
About Medscape  Privacy & Ethics  Terms of Use  Help

All material on this website is protected by copyright, Copyright © 1994-2002 by Medscape. This website also contains material copyrighted by 3rd parties. Medscape requires 4.x browsers or better from Netscape or Microsoft.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.